I have over 30 years experience in the multinational pharmaceutical and biotechnology industries spanning senior roles in Research and Development, Marketing, Sales and Strategic Planning. I have founded multiple biotechnology companies raising over $50MM in venture capital funding and achieved an IPO.I have taught undergraduates, graduates, and in executive education programs focusing on Marketing, Sales, Strategy, Entrepreneurship and Innovation Management.
I have over 30 years’ experience in the multinational pharmaceutical and biotechnology industries spanning senior roles in Research and Development, Marketing, Sales and Strategic Planning, including managerial positions with Sanofi-Aventis, GlaxoSmithKline, DuPont-Merck Pharmaceuticals, Gemini Genomics Inc. and Locus Pharmaceuticals Inc. Key positions held include: Head of Marketing and Sales, Vice President, Marketing and Business Development, and Chief Business Officer. I was also previously CEO of Nuevolution A/S based in Copenhagen, Denmark (acquired by Amgen) and CEO of Marillion Pharmaceuticals Inc. Presently I serve as Executive Chairman of Eppin Pharma Inc and CEO of Aestas Pharma Inc, both emerging biopharmaceutical companies. I have also raised over $50MM from venture capital firms to fund biotechnology enterprises, and have been instrumental in establishing more than 40 collaborations and co-operative agreements with major pharmaceutical and biotech companies, including licensing, co-marketing and acquisition transactions valued in excess of $600MM. Other career highlights include the successful launches of "blockbuster" drugs, including Imitrex®, Celexa®, Prinivil®/Zestril®, Sinemet CR® and Viazem®/Tiazac®, and the successful $100 MM IPO of Gemini Genomics Inc. and it's subsequent $220MM sale to Sequenom Inc.
- BS Pharmacology, 1979
- MS Applied Industrial Psychology, 1981
- PhD Psychology (Psychopharmacology), 1985
- MBA Marketing and Strategic Management, 1988
- LLB/JD Law, 1993
Marketing, Entrepreneurship, Innovation Management